Option chain shows key data for Diasorin's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Diasorin.

Diasorin (OTC:DSRLF) Stock, Option Chain

DiaSorin, headquartered in Italy, is a global provider of in vitro diagnostics, or IVD, which refers to testing done on samples taken from the human body, such as blood and tissue. DiaSorin produces and markets testing reagent kits for immunodiagnostics (about 65% of total sales) and molecular diagnostics (about 20%) and has a total installed base of about 9,000 diagnostic systems. Instruments and other revenue contribute about 15% of total sales. DiaSorin's largest market in 2023 was North America, which accounted for 48% of non-covid revenue, followed by Europe (35%) and the Rest of the World (18%).

Biotech

News

Health Care

Small Cap

General

DSRLF

LMNX

DiaSorin Acquires COVID-19 Test Maker Luminex For $37 Per Share

Diasorin SpA

DiaSorin S.p.A. 2023 Q4 - Results - Earnings Call Presentation

DiaSorin S.p.A. (DSRLF) Q4 2023 Earnings Call Transcript

European buy-rated quality stocks with under 50% beta, cheap on P/E relatives and low crowding - UBS

DiaSorin S.p.A. 2024 Q2 - Results - Earnings Call Presentation

DiaSorin S.p.A. (DSRLF) Q2 2024 Earnings Call Transcript

Invesco International Small-Mid Company Fund Q2 2024 Review

BRKR

CCDBF

CCLLF

CHHMF

CZMWF

CZMWY

DSGX

ELMUF

ETTYF

HEINY

HLMAF

KNYJF

LDSVF

MKGAF

MONRF

MPZAF

MPZAY

MSSMY

MSUXF

NCSYF

NICE

NSRGY

OBIIF

PGPHF

SDTHF

SPXSF

SPXSY

SWZCF

SYIEF

TELNF

VZIO

XINXF

YMATF

Diasorin

Comments

Diasorin

Diasorin (DSRLF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga